The Efficacy and Safety of Canaloplasty Vs Trabeculectomy Either Standalone or Combined with Cataract Surgery: An Updated Meta-Analysis

Author:

Abdelaal Abdelaziz1,Badr Helmy2,Serhan Hashem Abu3,Elmallahy Mohamed2,Ebrahim Mohamed2,Abuelazm Mohamed2,Abdallah Ahmed2,Ebrahim Abdulrahman2,Katamesh Basant E.2,Abdelazeem Basel4

Affiliation:

1. Tanta University, El-Gharbia Governorate

2. Tanta Research Team (TRT)

3. Hamad Medical Corporations

4. McLaren Health Care

Abstract

Abstract To compare the efficacy and safety between trabeculectomy (TE) and canaloplasty (CP) either as standalone or combined with phacoemulsification (PTE and PCP). Nine databases were searched for studies reporting efficacy and safety of TE/PTE and CP/PCP. Efficacy endpoints included postoperative intraocular pressure (IOP), complete, and qualified success, while safety endpoints included failure, revision surgery, and complications. STATA was used to pool the crude mean difference (MD) or log odds ratio (logOR) for continuous and categorical outcomes, respectively. Fourteen studies were included. TE/PTE was associated with lower IOP when compared to CP/PCP [MD=-2.55; 95%CI=-3.30: -1.80, I2 = 61.43%]. Similarly, TE/PTE was associated with significantly higher odds of complete [logOR = 1.20; 95%CI = 0.79:1.61, I2 = 7.41] and qualified success [logOR = 0.64; 95%CI = 0.16:1.13, I2 = 0%] when compared to CP/PCP, respectively. Although no significant differences in failure and revision surgery were noted between TE/PTE and CP/PCP, in the TE subgroup, a significant reduction in failure was observed as compared to CP [logOR=-0.82; 95%CI=-1.61: -0.04, I2 = 28.18%]. TE/PTE was associated with higher odds for hypotony and choroidal detachment and lower odds for Descemet’s membrane detachment and hyphema. TE/PTE has superiority over CP/PCP regarding IOP control and revision surgery rates. However, the certainty of these findings is low to very low.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3